skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Spleen Tyrosine Kinase Inhibitor TAK-659 (Code C113162)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Spleen Tyrosine Kinase Inhibitor TAK-659

Definition: An inhibitor of spleen tyrosine kinase (syk), with potential anti-inflammatory, immunomodulating, and antineoplastic activities. Spleen tyrosine kinase inhibitor TAK-659 may inhibit the activity of syk, which abrogates downstream B-cell receptor (BCR) signaling and leads to an inhibition of B-cell activation, chemotaxis, adhesion and proliferation. Syk, a BCR-associated non-receptor tyrosine kinase that mediates diverse cellular responses, including proliferation, differentiation, and phagocytosis, is expressed in hematopoietic tissues and is often overexpressed in hematopoietic malignancies.

Display Name: Spleen Tyrosine Kinase Inhibitor TAK-659

Label: Spleen Tyrosine Kinase Inhibitor TAK-659

NCI Thesaurus Code: C113162 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL455236  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Spleen Tyrosine Kinase Inhibitor TAK-659
Spleen Tyrosine Kinase Inhibitor TAK659
syk-Inhibitor TAK-659
syk-Inhibitor TAK659
syk Inhibitor TAK-659
syk Inhibitor TAK659

External Source Codes: 
PDQ Closed Trial Search ID 755930
PDQ Open Trial Search ID 755930 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C113162
Contributing_Source CTRP
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom